Immune desert in MMR-deficient tumors predicts poor responsiveness of immune checkpoint inhibition.
Zheng G, Lu Y, Yang Z, Chen H, Liang Q, Zhu Q, Li Y, Xiao X, He Z, Zhu Y, Li B, Huang L, Dong N, Hu S, Pan Y, Zhang C, Zhu C.
Zheng G, et al. Among authors: xiao x.
Front Immunol. 2023 Apr 28;14:1142862. doi: 10.3389/fimmu.2023.1142862. eCollection 2023.
Front Immunol. 2023.
PMID: 37187745
Free PMC article.